More Published Data on ' Game-Changer ' Drug for Obesity More Published Data on ' Game-Changer ' Drug for Obesity
Subcutaneous semaglutide once-weekly together with a low-calorie diet and intensive behavioral therapy leads to over 10% greater weight loss than placebo, shows the STEP 3 study published in JAMA.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news
More News: Diabetes | Diets | Eating Disorders & Weight Management | Endocrinology | Health | Nutrition | Obesity | Study | Weight Loss